At Sandoz, Peters currently serves as Global Head Clinical Development Biopharmaceuticals. Previously, he spent 12 years in various managerial positions within Novartis, where he managed the clinical development of oncology-related development projects.

Peters held teaching appointments in Internal Medicine and Biochemistry at the University of Mainz, Germany. He received his MD degree from the Freie Universität Berlin, Germany, and trained at the Universities of Padova, Italy and Bochum and Berlin, Germany. After scientific work at different universities he received his habilitation in Internal Medicine at the University of Mainz, Germany. Subsequently, he served as Research Scientist at the Amgen Research Institute in Toronto, Canada, as Director of Cancer Research at Merck KgaA in Darmstadt, Germany and as Medical Director at Micromet AG in Munich, Germany.